AIA Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
AIA Group's GILD Position: Q3 2026 in Review
AIA Group reduced its Gilead Sciences (GILD) stake by 18% in Q3 2026, selling an estimated $1M and leaving 32,632 shares worth $4.86M. The position accounts for 0.06% of the portfolio, ranked #149.
AIA Group first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.15M in Q3 2025. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- AIA Group held 32,632 shares of Gilead Sciences worth $4.86M as of Q3 2026.
- AIA Group sold 7,132 Gilead Sciences shares in Q3 2026, an estimated $1M.
- Gilead Sciences made up 0.06% of AIA Group's portfolio in Q3 2026, its #149 holding.
- AIA Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
- AIA Group's Gilead Sciences position peaked at $5.15M in Q3 2025.
- 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on AIA Group's 13F filing for Q3 2026, filed 30 Oct 2026.